Latest market price
11.66
-0.81-6.50%
OverviewShort InterestFilings
NTLAQT30Intellia Therapeutics, Inc.·NASDAQ
11.66-6.50%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 28, 20264Statement of changes in beneficial ownership
Oct 28, 20263Initial statement of beneficial ownership
Oct 06, 20264Statement of changes in beneficial ownership
Sep 08, 20268-KCurrent report
Sep 04, 20268-KCurrent report
Aug 24, 20264Statement of changes in beneficial ownership
Aug 07, 2026SC 13GBeneficial ownership statement (passive)
Aug 06, 20268-KCurrent report
Aug 06, 202610-QQuarterly report
Jul 24, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jul 06, 20264Statement of changes in beneficial ownership
Jun 15, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
May 11, 202610-QQuarterly report
May 11, 20268-KCurrent report
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 2026ARSAnnual report to shareholders
#1 / 25 of 351
Page
▼
/ 15